Obesity caused by melanocortin-4 receptor mutations;Obesitas door melanocortine-4-receptormutaties

Nederlands Tijdschrift voor Geneeskunde

Volumn 156, Issue 32, 2012, Pages

  Van Den Berg, Linda ^a   Glorie Docter, Miriam ^a   Van Den Akker, Erica ^b   Van De Waal, Henriette A Delemarre ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOCORTIN 4 RECEPTOR;

ARTICLE; OBESITY;

EID: 84873605941     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320:1240-3. (Pubitemid 30240471)
2. Rotteveel J, Felius A, van Weissenbruch MM, Delemarre-van de Waal HA. Insulin resistance and the metabolic Syndrome in Obese Children Referred to an Obesity Center Journal of Pediatric Endocrinology & Metabolism. J Pediatr Endocrinol Metab. 2010;23:943-51.
3. Factsheet. Resultaten vijfde landelijke groeistudie.TNO;2010.
4. Schokker DF, Visscher TL, Nooyens AC, van Baak MA, Seidell JC. Prevalence of overweight and obesity in the Netherlands. Obes Rev. 2007;8:101-8.
5. Van den Berg L, Delemarre-van de Waal H. Programmering van eetgedrag. Praktische Pediatrie. 2010;2:16-21.
6. Remmers F, Delemarre-van de Waal HA. Developmental programming of energy balance and its hypothalamic regulation. Endocr Rev. 2011;32:272-311.
7. Kalsbeek A, Bruinstroop Yi CX, Klieverik LP, La Fleur SE, Fliers E. Hypothalamic control of energy metabolism via the autonomic nervous system. Ann N Y Acad Sci. 2010;1212:114-29.
8. Bell CG, Walley AJ, Froquet P. The genetics of human obesity. Nat Rev Genet. 2005;6:221-34. (Pubitemid 40293032)
9. Adan RA, Tiesjema B, Hillebrand JJ, la Fleur SE, Kas MJ, de Krom M. The MC4 receptor and control of appetite. Br J Pharmacol. 2006;149:815-27. (Pubitemid 44851706)
10. Berg L van den, Pieterse K, Malik JA, Luman M, Willems van Dijk K, Oosterlaan J, et al. Association between impulsivity, reward responsiveness and body mass index in children. Int J Obes. 2011;35:1301-7.
11. Wardle J, Carnell S, Haworth CM, Plomin R. Evidence for a strong genetic influence on childhood adiposity despite the force of the obesogenic environment. Am J Clin Nutr. 2008;87:398-404. (Pubitemid 351226077)
12. Farooqi IS. Monogenic human obesity. Front Horm Res. 2008;36:1-11.
13. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med. 2003;348:1085-95. (Pubitemid 36337319)
14. Hainerová I, Larsen LH, Holst B, et al. Melanocortin 4 receptor mutations in obese Czech children: studies of prevalence, phenotype development, weight reduction response, and functional analysis. J Clin Endocrinol Metab. 2007;92:3689-96. (Pubitemid 47435357)
15. Lubrano-Berthelier C, Dubern B, Lacorte JM, et al. Melanocortin-4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating. J Clin Endocrinol Metab. 2006;91:1811-8.
16. Stutzmann F, Tan K, Vatin V, et al. Prevalence of melanocortin-4 receptor deficiency in Europeans and their age-dependent penetrance in multigenerational pedigrees. Diabetes. 2008;57:2511-8.
17. Dubern B, Bisbis S, Talbaoui H, et al. Homozygous null mutations of the melanocortin-4 receptor and severe early-onset obesity. J Pediatr. 2007;150:613-7.
18. Van den Berg L, van Beekum O, Heutink P, et al. Melanocortin-4 receptor gene mutations in a Dutch cohort of obese children. Obesity. 2011;19:604-11.
19. Partnerschap Overgewicht Nederland, Zorgstandaard Obesitas. Amsterdam; 2010.
20. Reinehr T, Hebebrand J, Friedel S, et al. Lifestyle intervention in obese children with variations in the melanocortin 4 receptor gene. Obesity. 2009;17:382-9.
21. Aslan IR, Ranadive SA, Ersoy BA, Rogers SJ, Lustig RH, Vaisse C. Bariatric surgery in a patient with complete MC4R deficiency. Int J Obes. 2011;35:457-61.
22. Potoczna N, Branson R, Kral JG, et al. Gene variants and binge eating as predictors of comorbidity and outcome of treatment in severe obesity. J Gastrointest Surg. 2004;8:971-82. (Pubitemid 39600639)
23. Razquin C, Marti A, Martinez JA. Evidences on three relevant obesogenes: MC4R, FTO and PPARγ. Approaches for personalized nutrition. Mol Nutr Food Res. 2011;55:136-49.
24. Roubert P, Dubern B, Plas P, et al. Novel pharmacological MC4R agonists can efficiently activate mutated MC4R from obese patient with impaired endogenous agonist response. J Endocrinol. 2010;207:177-83.
25. He S, Ye Z, Dobbelaar PH, Sebhat IK, Guo L, Liu J, et al. Spiroindane based amides as potent and selective MC4R agonists for the treatment of obesity. Bioorg Med Chem Lett. 2010;20:4399-405.
26. Krishna R, Gumbiner B, Stevens C, et al. Potent and selective agonism of the melanocortin receptor 4 with MK-0493 does not induce weight loss in obese human subjects: energy intake predicts lack of weight loss efficacy. Clin Pharmacol Ther. 2009;86:659-66.
27. Aslan IR, Campos GM, Calton MA, Evans DS, Merriman RB, Vaisse C. Weight loss after Roux-en-Y gastric bypass in obese patients heterozygous for MC4R mutations. Obes Surg. 2011;21:930-4.
28. Aslan IR, Ranadive SA, Ersoy BA, Rogers SJ, Lustig RH and Vaisse C. Bariatric surgery in a patient with complete MC4R deficiency. Int J Obes. 2011;35:457-61.